EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Access Latin America's vast landscape of untapped potential

Manufacturing and biodiversity

Latin America has a robust biosimilar and biopharmaceutical manufacturing sector. Latin America has biodiversity which includes a large number of species and biological assets.

Biotech innovation

You will find biotech Innovation all over Latin America in small biotech enterprises that are actively tackling endemic problems.

A rapidly expanding pharma market

Since 2008, Latin America represents the fastest growing pharmaceutical market in the world. By 2017, Brazil will become the fourth largest pharma market, behind the U.S., China and Japan. 

The Latin America pharma market was estimated by IMS at USD 68B in 2013, expanding at a 12% CAGR to over $110B by 2017. Some analysts predict that the overall revenue for the Latin American pharmaceutical market will reach USD 87.29 billion by 2018.

Better access to pharmacies

The largest drugstore chain in Latin America is Farmacias Ahumada S.A. (Fasa), based in Santiago, Chile, with a network of nearly 1,000 pharmacies in Chile, Peru, Brazil, and Mexico.

Special incentives

Latin America is a major hotbed of pharmaceutical and supply chain growth. Many countries in Latin America offer special incentives such as tax, labor and immigration benefits for global companies.